I

IDEAYA Biosciences
D

IDYA

21.890
USD
0.18
(0.83%)
مغلق
حجم التداول
26,130
الربح لكل سهم
-3
العائد الربحي
-
P/E
-7
حجم السوق
1,916,193,489
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARVN
    -0.600
    (-3.27%)
    17.750 USD
    C
    CRNC
    -0.900
    (-6.69%)
    12.560 USD
    C
    CUE
    -0.04700
    (-3.42%)
    1.32800 USD
    F
    FATE
    -0.13500
    (-8.74%)
    1.41000 USD
    I
    ICAD
    -0.12000
    (-4.26%)
    2.70000 USD
    T
    TDOC
    -1.190
    (-9.38%)
    11.490 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    المزيد
الأخبار
المقالات

العنوان: IDEAYA Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.